ArticleClinical and translational medicine2026

STK25 inhibits cancer-associated fibroblast activation to overcome cetuximab resistance in colorectal cancer.

Yifan Hou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.